Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...
Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an exclusive global licensing deal with ...
Roche Holdings AG on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant combined with palbociclib in advanced cancer patients. Trial Misses Primary Goal The trial ...
Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...
A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...
A combination of Merck’s Keytruda and Pfizer’s Padcev could offer a chemotherapy-free treatment alternative for patients with ...
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.
The continuous movement of the vocal cords weakens and eventually stops as laryngeal cancer progresses. Researchers have, for ...
Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...
The Biologics Price Competition and Innovation Act of 2009 created the abbreviated approval pathway that biosimilars rely on, and the FDA has approved 82 biosimilars to date, with the new guidance is ...
The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results